Hospital
Plains Hospital Corporation
Plains Hospital Corporation was paid $369K by Medicaid between Jan 2018 and Dec 2024, across 90 billing codes. Its largest line is 99283, emergency room visit (moderate) — 59% of everything it billed.
33Billing provider infoPLAINS HOSPITAL CORPORATION
PLAINS, MT 59859
PLAINS, MT 59859
33aNPI1265547939assigned 08/20/2006
33bProvider typeCritical Access Hospital
28Total paid$369K
24GClaims124,622
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Montana
Rank by total paid#11 of 25
Median peer was paid$185K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,761 | $66K | |
| 2019 | 20,270 | $67K | |
| 2020 | 17,073 | $50K | |
| 2021 | 19,201 | $56K | |
| 2022 | 19,465 | $70K | |
| 2023 | 17,454 | $40K | |
| 2024incomplete | 11,398 | $19K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 59% | 7,559 | 6,208 | $219K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 3,860 | 2,902 | $44K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 2,944 | 2,047 | $12K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.0% | 811 | 667 | $11K |
| 80053 | Comprehensive metabolic panel | 2.5% | 10,650 | 8,070 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.4% | 410 | 346 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 542 | 496 | $8K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 7,694 | 2,235 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.7% | 1,748 | 671 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 2,327 | 1,788 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 11,165 | 8,190 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,635 | 2,018 | $3K |
78 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,334 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,426 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,055 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,740 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,901 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 829 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,446 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,190 | $1K |
| 86140 | <1% | 2,266 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 920 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 859 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 219 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 336 | $989.23 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,183 | $902.75 |
| 81001 | <1% | 2,684 | $824.14 | |
| 83605 | <1% | 1,279 | $672.51 | |
| 83690 | <1% | 1,777 | $625.51 | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,413 | $624.64 |
| 87040 | <1% | 416 | $618.62 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 760 | $607.76 |
| G0378 | Hospital observation service, per hour | <1% | 166 | $549.63 |
| 85027 | <1% | 1,339 | $537.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,588 | $503.55 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,617 | $470.67 |
| 97161 | <1% | 243 | $451.44 | |
| 84484 | <1% | 2,649 | $427.95 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 127 | $426.68 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,174 | $400.44 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,477 | $317.20 |
| 80061 | Lipid panel | <1% | 2,042 | $266.93 |
| 81003 | <1% | 1,383 | $226.70 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 78 | $204.60 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 980 | $188.97 |
| 85651 | <1% | 633 | $186.20 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,175 | $176.46 |
| 85379 | <1% | 625 | $164.31 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,643 | $161.62 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 102 | $148.86 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 13 | $144.80 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 109 | $137.87 |
| 96376 | <1% | 176 | $134.63 | |
| 87420 | <1% | 15 | $111.46 | |
| 87077 | <1% | 56 | $110.29 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 78 | $101.70 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 569 | $94.67 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 78 | $92.84 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $68.76 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 86 | $62.98 |
| J2704 | Injection, propofol, 10 mg | <1% | 574 | $53.82 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 405 | $47.95 |
| 84703 | <1% | 65 | $46.30 | |
| 85610 | <1% | 732 | $33.84 | |
| 87186 | <1% | 75 | $32.47 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 37 | $15.92 |
| 84439 | <1% | 99 | $14.62 | |
| 80305 | <1% | 356 | $11.98 | |
| 83735 | <1% | 140 | $10.20 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 142 | $0.00 |
| 73562 | 0% | 42 | $0.00 | |
| 73630 | 0% | 34 | $0.00 | |
| A7038 | Filter, disposable, used with positive airway pressure device | 0% | 14 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 163 | $0.00 |
| 73610 | 0% | 13 | $0.00 | |
| 73030 | 0% | 109 | $0.00 | |
| 72100 | 0% | 15 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 15 | $0.00 |
| 83540 | 0% | 14 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 15 | $0.00 |
| 86803 | 0% | 46 | $0.00 | |
| 85018 | 0% | 18 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 73 | $0.00 |
| A9270 | Non-covered item or service | 0% | 505 | $0.00 |
| 85730 | 0% | 34 | $0.00 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 0% | 44 | $0.00 |
| 97162 | 0% | 45 | $0.00 | |
| 83880 | 0% | 115 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 25 | $0.00 |
| 94760 | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOGAN, RUSSELL (EXECUTIVE ASSISTANT)